ArticlePharmacoEconomics1997

A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients.

R J Milne et al.PubMed ↗Publisher ↗

No numbers read from the abstract.